30 likes | 33 Views
Phase I studies are the first stage of clinical trials in drug development, designed to assess the safety and pharmacokinetics of a new drug in humans. These trials typically involve a small group of healthy volunteers who are closely monitored by medical staff. The primary goal of Phase I studies is to determine the maximum tolerated dose (MTD) of the drug and to evaluate its safety profile. Additionally, Phase I studies can provide important information about the pharmacokinetics of the drug, including how it is absorbed, distributed, metabolized, and excreted by the body. This information i
E N D